Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.
D000368:Aged; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002386:Cataract / Q000201:enzymology*; D002417:Cattle; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007908:Lens, Crystalline / Q000201:enzymology*; D008875:Middle Aged; D009924:Organ Culture Techniques; D010113:Oxyphenbutazone / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D012980:Sodium Salicylate / Q000494:pharmacology; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*; D013467:Sulindac / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D013467:Sulindac; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase; D010113:Oxyphenbutazone; D012980:Sodium Salicylate; D007213:Indomethacin